BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30020484)

  • 21. Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
    Schiffer JT; Magaret A; Selke S; Corey L; Wald A
    J Antimicrob Chemother; 2011 Nov; 66(11):2593-600. PubMed ID: 21865349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
    Perti T; Saracino M; Baeten JM; Johnston C; Diem K; Ocbamichael N; Huang ML; Selke S; Magaret A; Corey L; Wald A
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):201-8. PubMed ID: 23542637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
    Hollier LM; Wendel GD
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania.
    Tanton C; Weiss HA; LeGoff J; Changalucha J; Clayton TC; Ross DA; Belec L; Hayes RJ; Watson-Jones D
    Sex Transm Infect; 2011 Aug; 87(5):406-11. PubMed ID: 21653932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
    Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
    Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genital shedding of herpes simplex virus among men.
    Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.
    Wald A; Zeh J; Barnum G; Davis LG; Corey L
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):8-15. PubMed ID: 7503497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
    LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
    AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus: the importance of asymptomatic shedding.
    Koelle DM; Wald A
    J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():1-8. PubMed ID: 10855766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
    Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
    Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
    Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection.
    Johnston C; Magaret A; Son H; Stern M; Rathbun M; Renner D; Szpara M; Gunby S; Ott M; Jing L; Campbell VL; Huang ML; Selke S; Jerome KR; Koelle DM; Wald A
    JAMA; 2022 Nov; 328(17):1730-1739. PubMed ID: 36272098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
    Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
    AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HSV shedding.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
    Nagot N; Ouédraogo A; Foulongne V; Konaté I; Weiss HA; Vergne L; Defer MC; Djagbaré D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P;
    N Engl J Med; 2007 Feb; 356(8):790-9. PubMed ID: 17314338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Hormonal Contraception and Menstrual Cycle Timing on Genital Herpes Simplex Virus-2 Shedding and Lesions.
    Micks E; Son H; Magaret A; Selke S; Johnston C; Wald A
    Sex Transm Dis; 2019 Jan; 46(1):58-62. PubMed ID: 30148758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.